Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Retained Earnings (2021 - 2025)

LifeStance Health (LFST) has disclosed Retained Earnings for 5 consecutive years, with $345000.0 as the latest value for Q2 2025.

  • Quarterly Retained Earnings fell 86.95% to $345000.0 in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $345000.0 through Jun 2025, down 86.95% year-over-year, with the annual reading at $929000.0 for FY2024, 59.66% down from the prior year.
  • Retained Earnings for Q2 2025 was $345000.0 at LifeStance Health, up from -$817.6 million in the prior quarter.
  • The five-year high for Retained Earnings was $4.4 million in Q3 2023, with the low at -$817.6 million in Q1 2025.
  • Average Retained Earnings over 5 years is -$302.0 million, with a median of -$249.0 million recorded in 2021.
  • The sharpest move saw Retained Earnings surged 100.85% in 2023, then plummeted 39119.11% in 2024.
  • Over 5 years, Retained Earnings stood at -$357.1 million in 2021, then tumbled by 60.37% to -$572.6 million in 2022, then soared by 100.4% to $2.3 million in 2023, then tumbled by 59.66% to $929000.0 in 2024, then tumbled by 62.86% to $345000.0 in 2025.
  • According to Business Quant data, Retained Earnings over the past three periods came in at $345000.0, -$817.6 million, and $929000.0 for Q2 2025, Q1 2025, and Q4 2024 respectively.